Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma

Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma

<p>Abstract</p> <p>Background</p> <p>High expression of Bmi-1, a key regulatory component of the polycomb repressive complex-1, has been associated with many solid and hematologic malignancies including esophageal squamous cell carcinoma. However, little is known about...

Full description

Bibliographic Details
Main Authors:	Choy Bonnie, Bandla Santhoshi, Xia Yinglin, Tan Dongfeng, Pennathur Arjun, Luketich James D, Godfrey Tony E, Peters Jeffrey H, Sun Jun, Zhou Zhongren
Format:	Article
Language:	English
Published:	BMC 2012-10-01
Series:	BMC Gastroenterology
Subjects:	Esophageal adenocarcinoma Bmi-1 Squamous cell carcinoma Barrett’s esophagus Dysplasia High expression Biomarker Overall survival
Online Access:	http://www.biomedcentral.com/1471-230X/12/146

Similar Items

Impact of laparoscopic nissen fundoplication on non-Complicated Barrett′s esophagus
by: Ashraf A Mohamed, et al.
Published: (2011-01-01)

Evaluation of p53 protein expression in Barrett esophagus
by: Mahathi Krothapalli, et al.
Published: (2018-01-01)

Taking the Next Steps in Endoscopic Visual Assessment of Barrett’s Esophagus: A Pilot Study
by: Chis R, et al.
Published: (2021-04-01)

Current and Future Use of Esophageal Capsule Endoscopy
by: Junseok Park, et al.
Published: (2018-07-01)

Barrett's esophagus and eosinophilic esophagitis in a young pediatric patient with esophageal atresia
by: Li-Zsa Tan, et al.
Published: (2015-07-01)

Diagnosis and Management of Barrett’s Esophagus, Dysplasia and Early Esophageal Adenocarcinoma: Focusing on American and European Guidelines
by: Ah Young Yoo, et al.
Published: (2019-07-01)

Differentiating dysplasia markers in Barrette sophagus and adenocarcinoma
by: Adrian Mor, et al.
Published: (2019-11-01)

Early diagnostic potential of APC hypermethylation in esophageal cancer
by: Wang B, et al.
Published: (2018-02-01)

CD80 expression promotes immune surveillance in Barrett’s metaplasia
by: Melania Scarpa, et al.
Published: (2019-10-01)

Esophageal Adenocarcinoma Arising from Barrett's Epithelium in Taiwan
by: Chia-Hung Tu, et al.
Published: (2007-08-01)

Current status and future perspectives on the etiology of esophageal adenocarcinoma
by: Aaron P. Thrift, et al.
Published: (2012-02-01)

Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma
by: Anna M. J. van Nistelrooij, et al.
Published: (2015-01-01)

Barrett's esophagus: Ten years of experience at a tertiary care hospital center in Mexico
by: F. Valdovinos-Andraca, et al.
Published: (2018-01-01)

Prevention Strategies for Esophageal Cancer—An Expert Review
by: Elisa Marabotto, et al.
Published: (2021-05-01)

Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett’s esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC)
by: Candyce Hamel, et al.
Published: (2020-01-01)

Indomethacin-Induced Apoptosis in Esophageal Adenocarcinoma Cells Involves Upregulation of Bax and Translocation of Mitochondrial Cytochrome C Independent of COX-2 Expression
by: Sanjeev Aggarwal, et al.
Published: (2000-07-01)

Toll-like receptors in esophageal cancer
by: Joonas H Kauppila, et al.
Published: (2014-05-01)

Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples
by: Anna M. J. van Nistelrooij, et al.
Published: (2017-04-01)

Genomic and Transcriptomic Characteristics of Esophageal Adenocarcinoma
by: Sascha Hoppe, et al.
Published: (2021-08-01)

Esôfago de Barrett e displasia: critérios diagnósticos Barret's esophagus and dysplasia: diagnostic criteria
by: Maria Aparecida Marchesan Rodrigues
Published: (2004-06-01)

Influence of genetics on tumoral pathologies: The example of the adenocarcinoma arising in Barrett's esophagus Influencia de la genética en la patología tumoral: El ejemplo del adenocarcinoma desarrollado sobre el esófago de Barrett
by: Vincenzo Villanacci, et al.
Published: (2012-12-01)

Endoscopic diagnosis and therapies for Barrett esophagus: a review
by: Irving Waxman, et al.
Published: (2014-02-01)

The importance of a second opinion in the diagnosis of Barrett's esophagus: a "real life" study
by: Vincenzo Villanacci, et al.

The usefulness of white light endoscopy, narrow band imaging, and magnification for the optimization of diagnosis in Barrett’s esophagus
by: Boeriu Alina, et al.
Published: (2014-12-01)

Genome-wide tracts of homozygosity and exome analyses reveal repetitive elements with Barrets esophagus/esophageal adenocarcinoma risk
by: Visanu Wanchai, et al.
Published: (2019-03-01)

Urinary metabolomic signature of esophageal cancer and Barrett’s esophagus
by: Davis Vanessa W, et al.
Published: (2012-12-01)

Epidemiologic trends and geographic distribution of esophageal cancer in Canada: A national population‐based study
by: Leila Cattelan, et al.
Published: (2020-01-01)

Barrett’s esophagus and esophageal adenocarcinoma: biomarkers of proliferation, apoptosis, autophagy and angiogenesis
by: E. S. Petenyova, et al.
Published: (2021-01-01)

Prevalence and modern aspects of the treatment of patients with Barrett’s esophagus
by: V. V. Tsukanov, et al.
Published: (2018-10-01)

Buried Barrett’s Esophagus with High-Grade Dysplasia after Radiofrequency Ablation
by: Joana Castela, et al.
Published: (2019-05-01)

Interactive decision support for esophageal adenocarcinoma screening and surveillance
by: Thomas L. Vaughan, et al.
Published: (2019-06-01)

Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma
by: Jessie A. Elliott, et al.
Published: (2021-03-01)

Immunohistochemical expression analysis of MMP-1, TIMP-2 and p53 in Barrett’s esophagus, dysplasia and esophageal adenocarcinoma
by: Alejandro García-Varona, et al.
Published: (2021-05-01)

Treatment of long-segment Barrett’s adenocarcinoma by complete circular endoscopic submucosal dissection: a case report
by: Miki Kaneko, et al.
Published: (2018-01-01)

Modern aspects of treatment of hiatal hernia and its main complications
by: A. Yu. Usenko, et al.
Published: (2021-04-01)

Prevention of Barrett's metaplasia in a human model of duodenogastro-oesophageal reflux
by: Richard J. Cade, et al.
Published: (2013-09-01)

DINAMIC SCREENING OF PRECANCEROUS ESOPHAGUS USING MOLECULAR GENETIC ANALYSIS
by: V. V. Anishchenko, et al.
Published: (2020-12-01)

Relationship between time-varying status of reflux esophagitis and Helicobacter pylori and progression to long-segment Barrett’s esophagus: time-dependent Cox proportional-hazards analysis
by: Genki Usui, et al.
Published: (2020-08-01)

The Impact of Artificial Intelligence in the Endoscopic Assessment of Premalignant and Malignant Esophageal Lesions: Present and Future
by: Daniela Cornelia Lazăr, et al.
Published: (2020-07-01)

Bile salt receptor TGR5 is highly expressed in esophageal adenocarcinoma and precancerous lesions with significantly worse overall survival and gender differences
by: Pang CH, et al.
Published: (2017-02-01)

Cannot write session to /tmp/vufind_sessions/sess_t9msl40e5ool63svb9o41hal6l